| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |